NMDA受体:神经退行的一个古老但更新的目标
Joana M Marques1,2, Ricardo J Rodrigues1,2
1CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
NeuroSci
|October 24, 2025
概括
神经退行性疾病因特定大脑区域退化的原因和症状而有所不同. 了解这些差异是开发针对性治疗阿尔茨海默氏症和帕金森症等疾病的关键.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 神经退行性疾病包括一系列疾病,其特点是神经元结构和功能逐渐丧失.
- 这些情况表现出不同的临床表现和潜在的病理机制.
- 特定区域的神经退行是一个标志,影响疾病轨迹和症状学.
研究的目的:
- 阐明各种神经退行性疾病的不同病因和表型.
- 突出区域特异性神经退行和疾病特征之间的相关性.
- 为差异诊断和有针对性的治疗策略提供基础.
主要方法:
- 对不同神经退行性疾病患者的临床数据进行比较分析.
- 对神经病理学发现的审查,重点关注受影响的大脑区域.
- 整合遗传和分子数据以了解疾病机制.
主要成果:
- 在不同神经退行性疾病中,在疾病发病,进展率和认知/运动缺陷方面表现出显著的差异.
- 确定了与疾病表型相关的不同大脑区域中神经元损失的特定模式.
- 强调了病因异质性,包括遗传和环境因素.
结论:
- 神经退行性疾病不是单一的,有不同的原因和表现.
- 特定区域的神经退行严重影响了这些疾病的临床情况.
- 了解这些特点对于推进研究和临床管理至关重要.
相关概念视频
Enzyme-linked Receptors
85.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Nonsense-mediated mRNA Decay
11.7K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.7K


